Author: Michael Fawn
Michael Fawn
Michael Fawn is a cryptocurrency journalist and blockchain analyst with a passion for breaking down complex market trends into easy-to-understand insights. Covering everything from Bitcoin and Ethereum to emerging altcoins and Web3 innovation, Michael focuses on delivering accurate, timely, and engaging crypto news for investors and enthusiasts alike. With years of experience following the digital asset industry, Michael keeps readers informed on the latest developments shaping the future of finance.
DeFi Development Corp is proposing a $20 million preferred stock offering to fund its acquisition of more Solana (SOL) tokens.
Donald Trump’s initiative to lower drug prices is reportedly expanding, coinciding with a continued upward trend in healthcare stock values.
Russia’s Sberbank processed an estimated $46 billion in cryptocurrency trading during its first year of operation, indicating significant market activity.
Dialectic will introduce a new SpaceX yield vault on the Base network during September, offering users a new way to earn on digital assets.
Social trading platforms are abuzz with speculation about the next influential figure to spark significant crypto market movements, potentially mirroring ‘Roaring Kitty’.
Gome Energy has announced a significant swing to an interim loss of RMB 1.09 billion, impacting its financial performance.
Yunnan Water reported a narrowed interim loss of RMB 656 million. This represents an improvement in the company’s financial performance during the period.
Ocumension Bio-B announced the enrollment of the first patient in its Phase III clinical trial for OT-202, marking a significant step in the drug’s development.
Zall Smart Commerce has announced a significant financial setback, reporting an interim loss of RMB 1.15 billion. The company’s performance reflects challenges in its commerce…
China Biopharma has granted Cipla an exclusive license for the development and commercialization of its drug candidate, TQB2102.